SCHEMBL5505589

SCHEMBL5505589

CC(=O)Nc1nnc(SCC(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(C=C4CCN(Cc5ccc(O)cc5)C4=O)CS[C@H]23)s1.[Na]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.41
ALDH1A1 P00352 3/20 0.40
PTGS1 P23219 1/20 0.40
PDE4A P27815 1/20 0.40
KDR P35968 1/20 0.40
POLB P06746 4/20 0.40
TDP1 Q9NUW8 4/20 0.40
MAPT P10636 4/20 0.40
PKM P14618 2/20 0.40
HTT P42858 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40
CA5A P35218 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
PTGS2 P35354 2/20 0.39
LMNA P02545 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
SLC22A11 Q9NSA0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505583 0.99 NR1I2 (0.41) NR1I2ALDH1A1PTGS1PDE4AKDR
SCHEMBL5505584 0.93 TDP1 (0.43) NR1I2ALDH1A1PTGS1PDE4AKDR
SCHEMBL5504309 0.85 MAPT (0.47) NR1I2ALDH1A1KDRPOLBTDP1
SCHEMBL5504305 0.84 MAPT (0.47) NR1I2ALDH1A1KDRPOLBTDP1
SCHEMBL5507044 0.84 CA5A (0.46) NR1I2ALDH1A1POLBTDP1MAPT
SCHEMBL5507026 0.82 CA5A (0.46) NR1I2ALDH1A1POLBTDP1MAPT
SCHEMBL5501846 0.81 TDP1 (0.50) NR1I2ALDH1A1POLBTDP1MAPT
SCHEMBL5500601 0.81 MAPT (0.51) ALDH1A1POLBTDP1MAPTPKM
SCHEMBL5500594 0.81 MAPT (0.51) ALDH1A1POLBTDP1MAPTPKM
SCHEMBL5501836 0.80 TDP1 (0.50) NR1I2ALDH1A1POLBTDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841339-B1 Vinylpyrrolidinon cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-02-21 EP disclosed
US-6294668-B1 ANTIBACTERIAL ACTIVITY AGAINST BETA-LACTAM SENSITIVE AND RESISTANT GRAM-POSITIVE BACTERIA, SUCH AS STAPHYLOCOCCI, PNEUMOCOCCI, AND ENTEROCOCCI; USED IN THERAPY OF INFECTIOUS DISEASES CAUSED BY THOSE BACTERIA HOFFMAN-LA ROCHE INC. 2001-09-25 US disclosed
EP-0841339-A1 Vinylpyrrolidinon cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-05-13 EP disclosed